BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21375774)

  • 1. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.
    Ding X; Ji W; Li J; Zhang X; Wang L
    Radiat Oncol; 2011 Mar; 6():24. PubMed ID: 21375774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer.
    Chiang CL; Chen YW; Wu MH; Huang HC; Tsai CM; Chiu CH
    J Chin Med Assoc; 2016 May; 79(5):248-55. PubMed ID: 27036494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
    Ye X; Yang J; Stebbing J; Peng L
    BMC Pulm Med; 2022 Feb; 22(1):54. PubMed ID: 35123465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
    Cousin F; Desir C; Ben Mustapha S; Mievis C; Coucke P; Hustinx R
    Radiother Oncol; 2021 Apr; 157():47-55. PubMed ID: 33453313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
    Lu X; Wang J; Zhang T; Zhou Z; Deng L; Wang X; Wang W; Liu W; Tang W; Wang Z; Wang J; Jiang W; Bi N; Wang L
    Front Immunol; 2022; 13():918787. PubMed ID: 35795657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review.
    Wang M; Xu S; Zhu H
    Front Immunol; 2022; 13():823767. PubMed ID: 35280981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer.
    Aviram G; Yu E; Tai P; Lefcoe MS
    Can Assoc Radiol J; 2001 Dec; 52(6):385-91. PubMed ID: 11780548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Kimura T; Doi Y; Nakashima T; Imano N; Kawabata H; Nishibuchi I; Okabe T; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):778-87. PubMed ID: 26530746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
    Keene KS; Harman EM; Knauf DG; McCarley D; Zlotecki RA
    Am J Clin Oncol; 2005 Jun; 28(3):217-22. PubMed ID: 15923791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
    Lee SW; Choi EK; Lee JS; Lee SD; Suh C; Kim SW; Kim WS; Ahn SD; Yi BY; Kim JH; Noh YJ; Kim SS; Koh Y; Kim DS; Kim WD
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):996-1004. PubMed ID: 12829135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
    Hu X; Bao Y; Chen YY; Gao JM; Wang WH; Liu Y; He H; Sun ZW; Poudel S; Wang Y; Zhuang TT; Zhang L; Chen M
    Ai Zheng; 2008 Oct; 27(10):1088-93. PubMed ID: 18851790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.
    Vogelius IS; Westerly DC; Cannon GM; Mackie TR; Mehta MP; Sugie C; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):893-9. PubMed ID: 21477946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer.
    Saunders MI; Rojas A; Lyn BE; Wilson E; Phillips H
    Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):352-60. PubMed ID: 12555873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
    Noda-Narita S; Naito T; Udagawa H; Goto K; Miyawaki T; Mamesaya N; Nakashima K; Kenmotsu H; Shimokawaji T; Kato T; Hakozaki T; Okuma Y; Nakamura M; Nakayama Y; Watanabe H; Kusumoto M; Ohe Y; Horinouchi H
    Cancer Sci; 2023 Feb; 114(2):630-639. PubMed ID: 36285515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].
    Hu X; Bao Y; Zhang L; Cheng Y; Li K; Wang W; Liu Y; He H; Sun Z; Zhuang T; Wang Y; Chen J; Liang Y; Zhang Y; Zhao H; Wang F; Chen M
    Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):691-9. PubMed ID: 20673485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.